Quanterix Corp(QTRX)Finding the best opportunities to buy and sell stocks daily.
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 177 full-time employees. The firm offers single molecule array (Simoa) platform, which uses single molecule measurements to detect protein biomarkers. The firm is also focusing to enable and develop novel therapies and diagnostics to facilitate in healthcare for earlier detection, monitoring, prognosis and, ultimately, prevention of disease. Simoa focuses on research and clinical testing applications and significantly advances enzyme-linked immunosorbent assay (ELISA) technology which is capable of unprecedented protein detection sensitivity. The company also focuses on research and diagnostics for brain injuries, heart disease, cancer and other infectious diseases with its technology. The firm offers Simoa HD-1 analyzer, which is an automated immunoassay platform with multiplexing and custom assay capability.
All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.